A thymidylate synthase polymorphism is associated with increased risk for bone toxicity among children treated for acute lymphoblastic leukemia

被引:11
作者
Finkelstein, Yaron [1 ]
Blonquist, Traci M. [2 ]
Vijayanathan, Veena [3 ]
Stevenson, Kristen E. [2 ]
Neuberg, Donna S. [2 ]
Silverman, Lewis B. [2 ,4 ,5 ]
Vrooman, Lynda M. [2 ,4 ,5 ]
Sallan, Stephen E. [2 ,4 ,5 ]
Cole, Peter D. [3 ]
机构
[1] Univ Toronto, Hosp Sick Children, Toronto, ON, Canada
[2] Dana Farber Canc Inst, Boston, MA 02115 USA
[3] Albert Einstein Coll Med, Dept Pediat, Bronx, NY 10467 USA
[4] Boston Childrens Hosp, Boston, MA USA
[5] Harvard Med Sch, Boston, MA USA
关键词
acute lymphoblastic leukemia; avascular necrosis; fracture; methotrexate; osteonecrosis; therapy-related toxicity; COLI L-ASPARAGINASE; OXIDATIVE STRESS; OSTEONECROSIS; CHILDHOOD; FOLATE; GENE; METHOTREXATE; BLOOD; VITAMIN-B-12; HOMOCYSTEINE;
D O I
10.1002/pbc.26393
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundBone fractures and osteonecrosis frequently complicate therapy for childhood acute lymphoblastic leukemia (ALL). Bone toxicity has been associated with exposure to corticosteroids and methotrexate (MTX) and age greater than 10 years. We tested whether common genetic polymorphisms were associated with bone toxicity during treatment for ALL. ProcedureA total of 615 of 794 children enrolled on Dana Farber Cancer Institute ALL Consortium protocol 05-001 (NCT00400946) met eligibility criteria for inclusion in this analysis. Nineteen candidate polymorphisms were selected a priori, targeting genes related to glucocorticoid metabolism, oxidative damage, and folate physiology. Polymorphisms were genotyped using either PCR-based allelic discrimination or PCR product length analysis. ResultsTwenty percent of subjects were homozygous for two 28 bp repeats (2R/2R, where 2R is two 28-nucleotide repeats within the 5' untranslated region [UTR] of the thymidylate synthase [TS] gene) within the 5 UTR of the gene for TS. This 2R/2R genotype was associated with increased risk of osteonecrosis among children younger than 10 years at diagnosis (multivariable hazard ratio [HR] 2.71; 95%confidence interval [CI] 1.23-5.95; P = 0.013), and with bone fracture among children 10 years (multivariable HR 2.10; 95%CI 1.11-3.96; P = 0.022). No significant association was observed between TS genotype and red blood cell (RBC) folate, RBC MTX, or relapse risk. ConclusionsA common genetic variant is associated with increased risk of osteonecrosis among children younger than 10 years at diagnosis and with bone fractures among older children. These findings suggest that children and adolescents with the 2R/2R TS genotype should be closely monitored for the development of bone toxicity during therapy for ALL, and support a clinical trial testing the efficacy of protective interventions specifically in this vulnerable population.
引用
收藏
页数:9
相关论文
共 41 条
[1]  
ALLEGRA CJ, 1985, J BIOL CHEM, V260, P9720
[2]   The development of thromboembolism may increase the risk of osteonecrosis in children with acute lymphoblastic leukemia [J].
Badhiwala, Jetan H. ;
Nayiager, Trishana ;
Athale, Uma H. .
PEDIATRIC BLOOD & CANCER, 2015, 62 (10) :1851-1854
[3]   Polymorphism in the PAI-1 (SERPINE1) gene and the risk of osteonecrosis in children with acute lymphoblastic leukemia [J].
Bond, Jonathan ;
Adams, Stuart ;
Richards, Susan ;
Vora, Ajay ;
Mitchell, Christopher ;
Goulden, Nicholas .
BLOOD, 2011, 118 (09) :2632-2633
[4]  
Cashman KD, 2005, NUTR REV, V63, P29, DOI [10.1301/nr.2004.janr.29-36, 10.1111/j.1753-4887.2005.tb00108.x]
[5]   Pharmacodynamic properties of methotrexate and Aminotrexate™ during weekly therapy [J].
Cole, PD ;
Alcaraz, MJ ;
Smith, AK ;
Tan, J ;
Kamen, BA .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2006, 57 (06) :826-834
[6]   Polymorphisms in Genes Related to Oxidative Stress Are Associated With Inferior Cognitive Function After Therapy for Childhood Acute Lymphoblastic Leukemia [J].
Cole, Peter D. ;
Finkelstein, Yaron ;
Stevenson, Kristen E. ;
Blonquist, Traci M. ;
Vijayanathan, Veena ;
Silverman, Lewis B. ;
Neuberg, Donna S. ;
Sallan, Stephen E. ;
Robaey, Philippe ;
Waber, Deborah P. .
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (19) :2205-U117
[7]   SNP rs6265 Regulates Protein Phosphorylation and Osteoblast Differentiation and Influences BMD in Humans [J].
Deng, Fei-Yan ;
Tan, Li-Jun ;
Shen, Hui ;
Liu, Yong-Jun ;
Liu, Yao-Zhong ;
Li, Jian ;
Zhu, Xue-Zhen ;
Chen, Xiang-Ding ;
Tian, Qing ;
Zhao, Ming ;
Deng, Hong-Wen .
JOURNAL OF BONE AND MINERAL RESEARCH, 2013, 28 (12) :2498-2507
[8]   The COMT val158met polymorphism is associated with prevalent fractures in Swedish men [J].
Eriksson, Anna L. ;
Mellstrom, Dan ;
Lorentzon, Mattias ;
Orwoll, Eric S. ;
Redlund-Johnell, Inga ;
Grundberg, Elin ;
Holmberg, Anna ;
Ljunggren, Osten ;
Karlsson, Magnus K. ;
Ohlsson, Claes .
BONE, 2008, 42 (01) :107-112
[9]  
Fleury Isabelle, 2004, Am J Pharmacogenomics, V4, P331, DOI 10.2165/00129785-200404050-00006
[10]   A PAI-1 (SERPINE1) polymorphism predicts osteonecrosis in children with acute lymphoblastic leukemia:: a report from the Children's Oncology Group [J].
French, Deborah ;
Hamilton, Leo H. ;
Mattano, Leonard A., Jr. ;
Sather, Harland N. ;
Devidas, Meenakshi ;
Nachman, James B. ;
Relling, Mary V. .
BLOOD, 2008, 111 (09) :4496-4499